Teneligliptin is used to treat type 2 diabetes, especially in persons whose sugar levels are too high and cannot be controlled by dieting and exercising. It is used alone or in combination with other drugs to lower blood sugar levels. It is grouped under the following drug class(es): DPP-4 inhibitors and Hypoglycemics. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include teneligliptinum, Teliglietin and Teneli. Its PubChem CID is 11949652.
Teneligliptin
| CAS No | 760937-92-6 |
|---|---|
| Molecular Formula | C22H30N6OS |
| Molecular Weight | 426.6 g/mol |
| Synonyms | [(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Teneligliptin is used to treat type 2 diabetes, especially in persons whose sugar levels are too high and cannot be controlled by dieting and exercising. It is used alone or in combination with other drugs to lower blood sugar levels.
The listed CAS number is 760937-92-6.
The listed molecular formula is C22H30N6OS.
The listed molecular weight is 426.6 g/mol.
[(2S,4S)-4-[4-(5-methyl-2-phenylpyrazol-3-yl)piperazin-1-yl]pyrrolidin-2-yl]-(1,3-thiazolidin-3-yl)methanone.
The source lists teneligliptinum, Teliglietin and Teneli.